** Shares of telehealth firm Hims and Hers HIMS.N rise 16.1% to $67.94
** Co acquires at-home lab testing service Trybe Labs, which offers at-home blood draws and whole body testing for subscribers
** With at-home lab testing, customers will be able to access more information about their health and providers can recommend high-quality customized treatments - HIMS
** HIMS expects to roll out at-home testing over the next year
** HIMS funded the acquisition through cash on hand
** "All-in, our general view is that we need to hear more. Seeing a category expansion, or in this case service expansion, is not a surprise on the surface" - brokerage Leerink Partners
** Stock has risen 6x in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.